Transient Receptor Potential (TRP) Ion Channels Involved in Malignant Glioma Cell Death and Therapeutic Perspectives

by Florence Lefranc
Published 2021-08-01

The Sodium Pump α1 Subunit as a Potential Target to Combat Apoptosis-Resistant Glioblastomas

by Florence Lefranc, Robert Kiss
Published 2008-03-01

Therapy of breast cancer brain metastases: challenges, emerging treatments and perspectives

by Nuria Kotecki, Florence Lefranc, Daniel Devriendt, Ahmad Awada
Published 2018-06-01

Can Some Marine-Derived Fungal Metabolites Become Actual Anticancer Agents?

by Nelson G. M. Gomes, Florence Lefranc, Anake Kijjoa, Robert Kiss
Published 2015-06-01

Cyclic versus Hemi-Bastadins. Pleiotropic Anti-Cancer Effects: from Apoptosis to Anti-Angiogenic and Anti-Migratory Effects

by Peter Proksch, Robert Kiss, Karim Amighi, Hendrik Niemann, Florence Lefranc, Nathalie Wauthoz, Véronique Mathieu
Published 2013-03-01

The Amaryllidaceae Isocarbostyril Narciclasine Induces Apoptosis By Activation of the Death Receptor and/or Mitochondrial Pathways in Cancer Cells But Not in Normal Fibroblasts

by Patrick Dumont, Laurent Ingrassia, Sébastien Rouzeau, Fabrice Ribaucour, Stéphanie Thomas, Isabelle Roland, Francis Darro, Florence Lefranc, Robert Kiss
Published 2007-09-01

Combining Bevacizumab with Temozolomide Increases the Antitumor Efficacy of Temozolomide in a Human Glioblastoma Orthotopic Xenograft Model

by Véronique Mathieu, Nancy De Nève, Marie Le Mercier, Janique Dewelle, Jean-François Gaussin, Mischael Dehoux, Robert Kiss, Florence Lefranc
Published 2008-12-01

Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?

by Stefaan W. van Gool, Steven de Vleeschouwer, Florence Lefranc, Véronique Mathieu, Rémi Rosière, Karim Amighi, Matthias van Woensel, Nathalie Wauthoz
Published 2013-08-01

The Phylum Bryozoa: From Biology to Biomedical Potential

by Maria Letizia Ciavatta, Florence Lefranc, Leandro M. Vieira, Robert Kiss, Marianna Carbone, Willem A. L. van Otterlo, Nicole B. Lopanik, Andrea Waeschenbach
Published 2020-04-01

Marine-Derived Anticancer Agents: Clinical Benefits, Innovative Mechanisms, and New Targets

by Renato B. Pereira, Nikolai M. Evdokimov, Florence Lefranc, Patrícia Valentão, Alexander Kornienko, David M. Pereira, Paula B. Andrade, Nelson G. M. Gomes
Published 2019-06-01

Recurrent glioblastomas: Should we operate a second and even a third time?

by Yahia-Cherif Djamel-Eddine, MD, Olivier De Witte, MD, PhD, Christian Mélot, MD, PhD, MSciBiostat, Florence Lefranc, MD, PhD
Published 2019-12-01

Galectin 1 Proangiogenic and Promigratory Effects in the Hs683 Oligodendroglioma Model Are Partly Mediated through the Control of BEX2 Expression

by Marie Le Mercier, Shannon Fortin, Véronique Mathieu, Isabelle Roland, Sabine Spiegl-Kreinecker, Benjamin Haibe-Kains, Gianluca Bontempi, Christine Decaestecker, Walter Berger, Florence Lefranc, Robert Kiss
Published 2009-05-01

Chemistry of the Nudibranch <em>Aldisa andersoni</em>: Structure and Biological Activity of Phorbazole Metabolites

by Guido Cimino, Margherita Gavagnin, Florence Lefranc, Lisette D’Souza, Ernesto Mollo, Guido Villani, Emiliano Manzo, Helene Leclercqz, Robert Kiss, Véronique Mathieu, Maria Letizia Ciavatta, Genoveffa Nuzzo
Published 2012-08-01

Long-term Temozolomide Treatment Induces Marked Amino Metabolism Modifications and an Increase in TMZ Sensitivity in Hs683 Oligodendroglioma Cells

by Delphine Lamoral-Theys, Marie Le Mercier, Benjamin Le Calvé, Michal A. Rynkowski, Céline Bruyère, Christine Decaestecker, Benjamin Haibe-Kains, Gianluca Bontempi, Jacques Dubois, Florence Lefranc, Robert Kiss
Published 2010-01-01

The Fungal Metabolite Eurochevalierine, a Sequiterpene Alkaloid, Displays Anti-Cancer Properties through Selective Sirtuin 1/2 Inhibition

by Michael Schnekenburger, Véronique Mathieu, Florence Lefranc, Jun Young Jang, Marco Masi, Anake Kijjoa, Antonio Evidente, Hyun-Jung Kim, Robert Kiss, Mario Dicato, Byung Woo Han, Marc Diederich
Published 2018-02-01

Long-term In Vitro Treatment of Human Glioblastoma Cells with Temozolomide Increases Resistance In Vivo through Up-regulation of GLUT Transporter and Aldo-Keto Reductase Enzyme AKR...

by Benjamin Le Calvé, Michal Rynkowski, Marie Le Mercier, Céline Bruyère, Caroline Lonez, Thierry Gras, Benjamin Haibe-Kains, Gianluca Bontempi, Christine Decaestecker, Jean-Marie Ruysschaert, Robert Kiss, Florence Lefranc
Published 2010-09-01

In Vitro Growth Inhibitory Activities of Natural Products from Irciniid Sponges against Cancer Cells: A Comparative Study

by Yosr BenRedjem Romdhane, Monia Elbour, Marianna Carbone, Maria Letizia Ciavatta, Margherita Gavagnin, Véronique Mathieu, Florence Lefranc, Leila Ktari, Karim Ben Mustapha, Abdellatif Boudabous, Robert Kiss, Ernesto Mollo
Published 2016-01-01

4-IBP, a σ1 Receptor Agonist, Decreases the Migration of Human Cancer Cells, Including Glioblastoma Cells, In Vitro and Sensitizes Them In Vitro and In Vivo to Cytotoxic Insults of...

by Veronique Mégalizzi, Véronique Mathieu, Tatjana Mijatovic, Philippe Gailly, Olivier Debeir, Nancy De Neve, Marc Van Damme, Gianluca Bontempi, Benjamin Haibe-Kains, Christine Decaestecker, Yasuko Kondo, Robert Kiss, Florence Lefranc
Published 2007-05-01

Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy

by Matthias Van Woensel, Thomas Mathivet, Nathalie Wauthoz, Rémi Rosière, Abhishek D. Garg, Patrizia Agostinis, Véronique Mathieu, Robert Kiss, Florence Lefranc, Louis Boon, Jochen Belmans, Stefaan W. Van Gool, Holger Gerhardt, Karim Amighi, Steven De Vleeschouwer
Published 2017-04-01